Redefining bioactive small molecules from microbial metabolites as revolutionary anticancer agents
Cancer Gene Therapy – Redefining bioactive small molecules from microbial metabolites as revolutionary anticancer agents
Cancer Gene Therapy – Redefining bioactive small molecules from microbial metabolites as revolutionary anticancer agents
Matthew S. Johnson, MD, discusses a pilot study of Y-90 radioembolization plus pembrolizumab in patients with poor-prognosis hepatocellular carcinoma.
Nature – Genomic analysis suggests that the outbreak probably began in December or January, but a shortage of data is hampering efforts to pin down…
Signal Transduction and Targeted Therapy – Major depressive disorder: hypothesis, mechanism, prevention and treatment
Idalid Franco, MD, MPH, discusses the integration of immunotherapy, molecular biomarkers, and risk factors for recurrence into the endometrial cancer paradigm.
Molecular Psychiatry – Long COVID: plasma levels of neurofilament light chain in mild COVID-19 patients with neurocognitive symptoms
Nature – Genomic analysis suggests that the outbreak probably began in December or January, but a shortage of data is hampering efforts to pin down…
The FDA granted accelerated approval to tovorafenib for pediatric patients relapsed/refractory low-grade glioma with a BRAF fusion/rearrangement or a BRAF V600 mutation.
The FDA has approved lutetium Lu 177 dotatate for pediatric patients 12 years of age and older with SSTR)–positive GEP-NETs.
An abstract is unavailable.
After noticing a lump on the right side of his neck, Chu Nguyen, Ph.D., came to MD Anderson for a second opinion. Further testing revealed…